Defilade Capital Management, L.P.
Q2 2026 13F filing
Updated 27 days ago39 disclosed positions worth $746.9M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LLY ELI LILLY & CO | $46.9M | 39.1K | 6.28% | — |
| 2 | P PFE PFIZER INC | $42.7M | 1.77M | 5.71% | — |
| 3 | V VEEV VEEVA SYS INC | $42M | 236.7K | 5.62% | — |
| 4 | B BMRN BIOMARIN PHARMACEUTICAL INC | $39M | 682.0K | 5.22% | — |
| 5 | ? N/A PTC THERAPEUTICS INC | $35.4M | 433.7K | 4.74% | — |
| 6 | B BAX BAXTER INTL INC | $31.1M | 1.46M | 4.17% | — |
| 7 | I INSM INSMED INC | $30M | 281.8K | 4.02% | — |
| 8 | Z ZBH ZIMMER BIOMET HOLDINGS INC | $27.3M | 317.4K | 3.66% | — |
| 9 | P PODD INSULET CORP | $26.9M | 176.9K | 3.61% | — |
| 10 | T TMO THERMO FISHER SCIENTIFIC INC | $26M | 51.9K | 3.49% | — |
| 11 | A ABT ABBOTT LABORATORIES | $25.9M | 285.8K | 3.47% | — |
| 12 | A ASND ASCENDIS PHARMA A/S | $25.3M | 94.8K | 3.39% | — |
| 13 | S SOLV SOLVENTUM CORP | $24.4M | 316.5K | 3.27% | — |
| 14 | M MDT MEDTRONIC PLC | $23.7M | 303.3K | 3.18% | — |
| 15 | E ELAN ELANCO ANIMAL HEALTH INC | $21.3M | 864.1K | 2.85% | — |
| 16 | M MGRB AGIOS PHARMACEUTICALS INC | $20.3M | 546.8K | 2.72% | — |
| 17 | N NVST ENVISTA HOLDINGS CORPORATION | $19.1M | 726.1K | 2.56% | — |
| 18 | R RVMDW REVOLUTION MEDICINES INC | $15.5M | 82.8K | 2.08% | — |
| 19 | I ICUI ICU MED INC | $15.5M | 105.7K | 2.07% | — |
| 20 | C COGT COGENT BIOSCIENCES INC | $15.2M | 393.4K | 2.04% | — |
| 21 | L LNTH LANTHEUS HLDGS INC | $14.7M | 132.7K | 1.97% | — |
| 22 | O OCFC OCULAR THERAPEUTIX INC | $14.6M | 1.49M | 1.96% | — |
| 23 | E ELDN ELEDON PHARMACEUTICALS INC | $13.9M | 3.53M | 1.86% | — |
| 24 | T TYRA TYRA BIOSCIENCES INC | $12M | 376.9K | 1.61% | — |
| 25 | O OLMA OLEMA PHARMACEUTICALS INC | $11.6M | 924.8K | 1.55% | — |
| 26 | O ORIC ORIC PHARMACEUTICALS INC | $11.3M | 1.05M | 1.52% | — |
| 27 | L LRMR LARIMAR THERAPEUTICS INC | $11.2M | 3.67M | 1.50% | — |
| 28 | G GMED GLOBUS MED INC | $11M | 139.6K | 1.48% | — |
| 29 | E ENOV ENOVIS CORPORATION | $11M | 531.9K | 1.47% | — |
| 30 | E EVMN EVOMMUNE INC | $10.5M | 793.1K | 1.41% | — |
| 31 | T TFX TELEFLEX INCORPORATED | $10.2M | 80.1K | 1.36% | — |
| 32 | D DNLI DENALI THERAPEUTICS INC | $10.1M | 391.9K | 1.35% | — |
| 33 | G GKOS GLAUKOS CORP | $9.3M | 66.5K | 1.24% | — |
| 34 | S STAA STAAR SURGICAL CO | $9.2M | 322.1K | 1.24% | — |
| 35 | P PACS PACS GROUP INC | $9.2M | 215.7K | 1.23% | — |
| 36 | C CRNX CRINETICS PHARMACEUTICALS IN | $9M | 239.4K | 1.20% | — |
| 37 | L LIVN LIVANOVA PLC | $8.8M | 107.4K | 1.18% | — |
| 38 | B BDTX BLACK DIAMOND THERAPEUTICS I | $3.1M | 1.67M | 0.41% | — |
| 39 | M MREO MEREO BIOPHARMA GROUP PLC | $2.4M | 7.56M | 0.32% | — |